✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Testides
Batch SERM-CA-26D-01
Verification Progress
GLP-1 Receptor Agonist Research Peptide
Semaglutide is a GLP-1 receptor agonist studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance. In laboratory settings, it is commonly examined for how it influences insulin pathways and body weight–related mechanisms.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.
In scientific literature, semaglutide is studied in experimental models examining GLP-1 receptor activation pathways, incretin-related signaling cascades, and downstream endocrine regulatory dynamics under in vitro and preclinical research conditions.
Third-party tested for purity, identity, quantity.
Semaglutide is a synthetic, long-acting analogue of glucagon-like peptide-1 (GLP-1) evaluated in research focused on incretin receptor signaling activity. As a compound structurally engineered to interact with GLP-1 receptor systems with extended half-life, it is studied within experimental models examining receptor-driven signaling pathways and metabolic regulatory interaction.
Preclinical and clinical research publications have explored its receptor-binding profile, downstream pathway activation, and GLP-1 receptor signaling dynamics under controlled study conditions.
GLP-1 was identified during investigations into incretin hormone physiology and glucose-dependent insulin secretion. Early research established it as a short-acting endogenous signaling peptide, with subsequent investigations focused on developing structurally modified analogues with improved stability and extended receptor interaction profiles.
Semaglutide emerged from this lineage as a long-acting GLP-1 analogue incorporating structural modifications — including a C-18 fatty acid side chain and backbone substitutions — designed to enhance albumin binding and resistance to dipeptidyl peptidase-4 degradation within experimental systems.
Laboratory investigations into semaglutide have focused on GLP-1 receptor activation models and downstream incretin signaling pathways. Research frameworks evaluate receptor-mediated interaction, endocrine regulatory dynamics, and metabolic signaling mechanisms under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 10mg of lyophilized semaglutide. Independent third-party testing verifies purity, identity, and net content per batch.
The vial contains only the lyophilized compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide.
PubMedSemaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6).
PubMedOnce-weekly semaglutide in adults with overweight or obesity (STEP 1).
PubMedSemaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5.
PubMedRelated
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
Synthetic thymosin beta analog studied for cellular migration, actin regulation, and repair signaling pathways
From$60.00
